Jay Kenneth Fisher
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$12.4MFederal grants as PI17 awards
1Patents grantedLatest Apr 21, 2026
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
17 awards · $12.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 18, 2026 | NIH | SBIR Phase I Development of an automated, compact sample-to-sequencer ready system for extensively/multi drug-resistant TB detection | $307K | Redbud Labs, Inc. |
| Sep 17, 2025 | NIH | SBIR Phase II System for unitary automation of library preparation | $48K | Redbud Labs, Inc. |
| Aug 18, 2025 | NIH | SBIR Phase II Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation | $50K | Redbud Labs, Inc. |
| Aug 13, 2025 | NIH | SBIR Phase II Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation | $1.3M | Redbud Labs, Inc. |
| Mar 24, 2025 | NIH | SBIR Phase II System for unitary automation of library preparation | $1.2M | Redbud Labs, Inc. |
| Mar 19, 2025 | NIH | SBIR Phase II Rapid point-of-care molecular test for HCV VL | $997K | Redbud Labs, Inc. |
| Jul 3, 2024 | NIH | SBIR Phase II Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation | $1.2M | Redbud Labs, Inc. |
| May 20, 2024 | NIH | SBIR Phase II System for unitary automation of library preparation | $1.2M | Redbud Labs, Inc. |
| Apr 2, 2024 | NIH | SBIR Phase II Rapid point-of-care molecular test for HCV VL | $999K | Redbud Labs, Inc. |
| Aug 16, 2023 | NIH | SBIR Phase II A modular platform for infectious disease surveillance at point-of-need. | $984K | Redbud Labs, Inc. |
| Jul 14, 2023 | NIH | SBIR Phase II Point-of-care HIV viral load system using RPA and MXR | $950K | Redbud Labs, Inc. |
| Sep 15, 2022 | NIH | SBIR Phase I Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation | $279K | Redbud Labs, Inc. |
| Jul 14, 2021 | NIH | SBIR Phase II A modular platform for infectious disease surveillance at point-of-need. | $292K | Redbud Labs, Inc. |
| Aug 7, 2020 | NIH | SBIR Phase II A modular platform for infectious disease surveillance at point-of-need. | $299K | Redbud Labs, Inc. |
| Jul 24, 2020 | NIH | SBIR Phase II System for faster microarray assays and end-to-end workflow automation | $987K | Redbud Labs, Inc. |
| Dec 26, 2018 | NIH | SBIR Phase II Device for rapid extraction of rare pathogens from raw samples | $995K | Redbud Labs, Inc. |
| Jul 26, 2018 | NIH | SBIR Phase I Device for rapid, on-chip, sample-to-answer bacterial identification and drug susceptibility testing | $294K | Redbud Labs, Inc. |
2 patents as inventor
- US 12606865Redbud Labs, Inc.Apr 21, 2026
- US Redbud Labs, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#43
Awards as PI#45
Patents#284
Companies
- Redbud Labs, Inc.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.